Back to Trials
NCT06859710PHASE1RecruitingAccepts Healthy Volunteers

THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy

University of California, Los Angeles

Start Date

11/5/2025

Completion Date

9/1/2028

Summary

The purpose of this research is to assess the impact of CBD on the effects of THC.

Detailed Description

Some evidence indicates that cannabidiol (CBD), a non-intoxicating cannabis component, might mitigate certain effects of THC. This study will examine possible roles for CBD in modulating THC's adverse and analgesic effects.

Eligibility Criteria

Age Range: 21 years to 55 years

Inclusion Criteria: * Male or non-pregnant and non-lactating females aged 21-55 years * Report cannabis use 1-7 days per week over the month prior to screening * Not currently seeking treatment for their cannabis use * History of inhaled cannabis use * Have a Body Mass Index from 18.5 - 34 kg/m2 * Able to perform all study procedures * Must be using a contraceptive (hormonal or barrier methods) Exclusion Criteria: * Meeting DSM-V criteria for severe Cannabis Use disorder (CUD) or any substance use disorder other than nicotine, caffeine, mild or moderate CUD * Evidence of severe psychiatric illness (e.g. mood or anxiety disorder with functional impairment or suicide risk, schizophrenia) judged by the study physician (and PI) to put the participant at greater risk of experiencing adverse events due to completion of study procedures, interfere with their ability to participate in the study, or their capacity to provide informed consent. * Report using other illicit drugs in the prior 4 weeks * Current pain * Pregnancy * Currently enrolled in another research protocol * Not using a contraceptive method (hormonal or barrier methods) * Insensitivity to the cold water stimulus of the Cold Pressor Test * Any disorders that might make cannabis administration hazardous as determined by evaluation physician after review of all medical assessments along with medical history. * Not able to speak and read English

Interventions

DRUG

Placebo

DRUG

THC

DRUG

CBD 20 mg

DRUG

CBD 40 mg

DRUG

CBD 80 mg

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Abuse, DrugPain

Locations

UCLA Center for Cannabis and Cannabinoids

Los Angeles, California 90095

United States